Lopez-Garcia J A, Laird J M
Department of Physiology, School of Medicine, University of Alcalá, Alcalá de Henares, Madrid, Spain.
Neuroreport. 1998 Mar 9;9(4):647-51. doi: 10.1097/00001756-199803090-00016.
Non-steroidal anti-inflammatory drugs inhibit constitutive (COX-1) and induced cyclooxygenase (COX-2), blocking prostaglandin production. We have compared the effects on nociceptive reflexes of meloxicam, which is COX-2 selective, with indomethacin, which is non-selective, using an in vitro spinal cord preparation. Cords were taken from naive rats, and from rats with carrageenan-induced hyperalgesia of one hindpaw. Reflex thresholds were lower in carrageenan preparations. Superfusion with meloxicam (10-100 microM) dose-dependently inhibited baseline reflexes and wind-up in normal and carrageenan preparations, whereas indomethacin (100-300 microM) had no effect. Thus meloxicam inhibits spinal reflexes, whereas indomethacin does not, despite its high affinity for both COX isoforms. We conclude that meloxicam has spinal antinociceptive actions which cannot be explained by the current concept of COX inhibition.
非甾体抗炎药抑制组成型(COX-1)和诱导型环氧化酶(COX-2),阻断前列腺素的产生。我们使用体外脊髓制备方法,比较了COX-2选择性药物美洛昔康与非选择性药物吲哚美辛对伤害性反射的影响。脊髓取自未处理的大鼠以及角叉菜胶诱导一侧后爪痛觉过敏的大鼠。角叉菜胶处理的脊髓制备物中反射阈值较低。用美洛昔康(10 - 100微摩尔)进行灌注,剂量依赖性地抑制正常和角叉菜胶处理的制备物中的基线反射和后放电,而吲哚美辛(100 - 300微摩尔)则无作用。因此,尽管吲哚美辛对两种COX同工型都有高亲和力,但美洛昔康能抑制脊髓反射,而吲哚美辛不能。我们得出结论,美洛昔康具有脊髓抗伤害感受作用,这无法用当前的COX抑制概念来解释。